Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

NCT04863547 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT04863547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04863547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Observational
Overall status
Unknown status
Start date
March 11, 2021
Completion date
May 31, 2021
Enrollment
2,200 (estimated)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

severe acute respiratory syndrome coronavirus 2 (sars-cov-2)